Literature DB >> 9516481

A novel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration.

F Ono1, T Nakagawa, S Saito, Y Owada, H Sakagami, K Goto, M Suzuki, S Matsuno, H Kondo.   

Abstract

We report herein the cloning and characterization of a novel class II phosphoinositide 3-kinase, termed PI3K-IIgamma, from the cDNA library of regenerating rat liver. This cDNA encodes a protein of 1505 amino acids with a calculated molecular mass of 170,972 Da. The amino acid sequence of PI3K-IIgamma is highly similar to those of class II PI 3-kinases, including murine Cpk-m/p170 and human HsC2-PI3K. It contains a C2 domain at the C terminus but no recognizable protein motifs at its N terminus. PI3K-IIgamma displays a restricted substrate specificity for PtdIns and PtdIns 4-P, but not for PtdIns 4,5-P2. By epitope tag immunocytochemistry, the immunoreactivity for PI3K-IIgamma is localized in the juxtanuclear Golgi region at high levels and also in the plasma and nuclear membranes at low levels. By Northern blot analysis and in situ hybridization histochemistry, PI3K-IIgamma mRNA expression is confined to the liver throughout the development with much higher expression in adult liver than in fetal liver. In addition, its expression increases during liver regeneration after partial hepatectomy with maximal expression after the growth period, suggesting that PI3K-IIgamma may function mainly in highly differentiated hepatic cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516481     DOI: 10.1074/jbc.273.13.7731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Hepatocyte growth factor activates phosphoinositide 3-kinase C2 beta in renal brush-border plasma membranes.

Authors:  Vladiana Crljen; Stefano Volinia; Hrvoje Banfic
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

Review 2.  Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.

Authors:  David A Medina-Tato; Stephen G Ward; Malcolm L Watson
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

3.  A Trypanosoma cruzi phosphatidylinositol 3-kinase (TcVps34) is involved in osmoregulation and receptor-mediated endocytosis.

Authors:  Alejandra C Schoijet; Kildare Miranda; Wendell Girard-Dias; Wanderley de Souza; Mirtha M Flawiá; Héctor N Torres; Roberto Docampo; Guillermo D Alonso
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

4.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

5.  Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.

Authors:  A Arcaro; M J Zvelebil; C Wallasch; A Ullrich; M D Waterfield; J Domin
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 6.  PI3K: from the bench to the clinic and back.

Authors:  Bart Vanhaesebroeck; Peter K Vogt; Christian Rommel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.

Authors:  Kristi L Berger; Jacob D Cooper; Nicholas S Heaton; Rosa Yoon; Todd E Oakland; Tristan X Jordan; Guaniri Mateu; Arash Grakoui; Glenn Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-17       Impact factor: 11.205

Review 8.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 9.  Role of phosphoinositide 3-kinase signaling in mast cells: new insights from knockout mouse studies.

Authors:  Taro Fukao; Yasuo Terauchi; Takashi Kadowaki; Shigeo Koyasu
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

10.  Targeted expression of the class II phosphoinositide 3-kinase in Drosophila melanogaster reveals lipid kinase-dependent effects on patterning and interactions with receptor signaling pathways.

Authors:  Lindsay K MacDougall; Mary Elizabeth Gagou; Sally J Leevers; Ernst Hafen; Michael D Waterfield
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.